Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial (vol 165, pg 329, 2017)

Metadata

Authors/Creators:	Cortés, J Rugo, HS Awada, A Twelves, C Perez, EA Im, SA Gómez-Pardo, P Schwartzberg, LS Diéras, V Yardley, DA Potter, DA Mailliez, A Moreno-Aspitia, A Ahn, J-S Zhao, C Hoch, U Tagliaferri, M Hannah, AL O’Shaughnessy, J
Commentary on:	Cortés, J, Rugo, HS, Awada, A et al. (16 more authors) (2017) Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial. Breast Cancer Research and Treatment, 165 (2). pp. 329-341. ISSN 0167-6806
Dates:	Accepted: 7 September 2017 Published (online): 7 September 2017 Published: November 2017
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Clinical Cancer Research (Leeds)
Depositing User:	Symplectic Publications
Date Deposited:	11 Jul 2019 16:07
Last Modified:	11 Jul 2019 16:07
Status:	Published
Publisher:	Springer Nature
Identification Number:	https://doi.org/10.1007/s10549-017-4482-3
Related URLs:	Author

Cortés, J, Rugo, HS, Awada, A, Twelves, C, Perez, EA, Im, SA, Gómez-Pardo, P, Schwartzberg, LS, Diéras, V, Yardley, DA, Potter, DA, Mailliez, A, Moreno-Aspitia, A, Ahn, J-S, Zhao, C, Hoch, U, Tagliaferri, M, Hannah, AL and O’Shaughnessy, J Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial. (deposited 23 Jan 2019 15:55)
- Cortés, J, Rugo, HS, Awada, A, Twelves, C, Perez, EA, Im, SA, Gómez-Pardo, P, Schwartzberg, LS, Diéras, V, Yardley, DA, Potter, DA, Mailliez, A, Moreno-Aspitia, A, Ahn, J-S, Zhao, C, Hoch, U, Tagliaferri, M, Hannah, AL and O’Shaughnessy, J Erratum to: Prolonged survival in patients with breast cancer and a history of brain metastases: results of a preplanned subgroup analysis from the randomized phase III BEACON trial (vol 165, pg 329, 2017). (deposited 11 Jul 2019 16:07) [Currently Displayed]

CORE (COnnecting REpositories)